BLT 0.00% 10.5¢ benitec biopharma limited

Sanofi Signs Benitec's closest competitor Voyager for $845M

  1. 2,300 Posts.
    lightbulb Created with Sketch. 8

    Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager
    February 11, 2015 | By John Carroll

    Sanofi subsidiary Genzyme is tying up with gene therapy upstart Voyager Therapeutics, gambling $100 million upfront on the hot field and promising up to $745 million in milestones for their partnership on a full slate of development programs.

    Here's Dirk's blog from a year ago when his buddy and ex boss Mark Kay's new Co Voyager was announced :
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.